Danaparoide and heparin-induced thrombocytopaenia;Thrombopénie croisée aux héparines et au danaparoïde

Annales Francaises d'Anesthesie et de Reanimation

Volumn 20, Issue 1, 2001, Pages 50-53

  Godet, G ^a   Bertrand, M ^a   Van De Steen, E ^a   Boccara, G ^a   Koskas, F ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Danaparoid; Heparin; Thrombocytopaenia

Indexed keywords

CAPTOPRIL; CLOPIDOGREL; DANAPAROID; HEPARIN; HEPARIN CALCIUM; IMMUNOGLOBULIN; LEPIRUDIN; NADROPARIN; NORFLOXACIN; OMEPRAZOLE; SUCRALFATE;

AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; THROMBOCYTOPENIA;

EID: 0035133541     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(00)00333-6     Document Type: Article

References (12)

1. Arterial embolism during systemic heparin therapy
2. Thrombopénies induites par l'héparine
3. Heparin-induced thrombocytopenia
4. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight or unfractionated heparin
5. Heparin-induced thrombocytopenia: Pathogenesis, frequency, avoidance and management
6. Impact of the patient population on the risk for heparin-induced thrombocytopenia
7. Low molecular weight heparins and heparin-induced thrombocytopenia
8. Surgical management of heparin-associated thrombocytopenia
9. Management of cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia using prostaglandin E1 and aspirin
10. Orgaran (Danaparoid sodium) use in the syndrome of heparin-induced thrombocytopenia
11. Determination of heparin-induced IgG antibody in heparin-induced thrombocytopenia type II
12. In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery